Equitable Holdings’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $239K | Buy |
+4,911
| New | +$239K | ﹤0.01% | 1302 |
|
|
2024
Q4 | – | Sell |
-4,398
| Closed | -$207K | – | 1283 |
|
|
2024
Q3 | $207K | Buy |
+4,398
| New | +$207K | ﹤0.01% | 1177 |
|
|
2024
Q2 | – | Sell |
-4,853
| Closed | -$331K | – | 1219 |
|
|
2024
Q1 | $331K | Buy |
4,853
+1,162
| +31% | +$79.2K | ﹤0.01% | 931 |
|
|
2023
Q4 | $231K | Buy |
+3,691
| New | +$231K | ﹤0.01% | 1025 |
|